NCT05651516View on ClinicalTrials.gov

Tau PET Imaging in Opioid Use Disorder

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 25, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Opioid-Related Disorders
Interventions
DRUG

18F-PI-2620 PET/CT

PET/CT imaging will be used to evaluate the uptake of tau in the brain using the investigational radiotracer \[18F\]PI-2620. Each subject will have one \[18F\]PI-2620 positron emission tomography/computed tomography (PET/CT) scan performed.

Trial Locations (1)

19104

RECRUITING

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

Yale University

OTHER

lead

University of Pennsylvania

OTHER